Ruxolitinib for myelofibrosis

N Engl J Med. 2012 May 24;366(21):2032; author reply 2032-5. doi: 10.1056/NEJMc1203704.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Female
  • Humans
  • Janus Kinase 1 / antagonists & inhibitors*
  • Janus Kinase 2 / antagonists & inhibitors*
  • Male
  • Primary Myelofibrosis / drug therapy*
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrazoles / therapeutic use*
  • Splenomegaly / drug therapy*

Substances

  • Protein Kinase Inhibitors
  • Pyrazoles
  • Janus Kinase 1
  • Janus Kinase 2